Teva Pharmaceuticals has recalled 3,623 bottles of Valganciclovir Hydrochloride for Oral Solution (50 mg/mL). This prescription medication, which is the generic version of Valcyte, is being recalled because brown or black particles were discovered in the liquid during stability testing. Consumers should not use the affected medication as the presence of these foreign substances could lead to adverse health effects. This product was distributed to wholesalers and distributors throughout the United States.
The presence of foreign brown or black particles in an oral medication poses a risk of irritation or injury to the digestive tract or other unexpected immune responses. While no specific injuries have been reported yet, any foreign substance in a pharmaceutical product is a significant quality failure that could compromise the safety and efficacy of the treatment.
Return to pharmacy for refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.